Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-08-19
1997-11-25
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
540517, 540567, A61K 3155, C07D28110
Patent
active
056913320
ABSTRACT:
This invention is concerned with novel compounds represented by structural formula I ##STR1## which are useful in the treatment of arrhythmia.
REFERENCES:
patent: 4470988 (1984-09-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4503060 (1985-03-01), Walther et al.
patent: 4507313 (1985-03-01), Braestrap et al.
patent: 4537885 (1985-08-01), Watthey
patent: 4600534 (1986-07-01), Bach et al.
patent: 4692522 (1987-09-01), Parsons et al.
patent: 4775671 (1988-10-01), Hunkeler et al.
patent: 4820834 (1989-04-01), Evans et al.
patent: 4847248 (1989-07-01), Freidinger et al.
patent: 4992437 (1991-02-01), Naka et al.
patent: 5004741 (1991-04-01), Evans et al.
patent: 5055464 (1991-10-01), Murakami et al.
patent: 5166151 (1992-11-01), Freidinger et al.
patent: 5206234 (1993-04-01), Bock et al.
patent: 5220018 (1993-06-01), Bock et al.
patent: 5302591 (1994-04-01), Fletcher et al.
patent: 5324726 (1994-06-01), Bock et al.
patent: 5338861 (1994-08-01), Botta et al.
patent: 5360802 (1994-11-01), Chambers et al.
patent: 5410049 (1995-04-01), Chambers
patent: 5426185 (1995-06-01), Baldwin et al.
patent: 5428157 (1995-06-01), Baldwin et al.
patent: 5438055 (1995-08-01), Baldwin et al.
patent: 5439905 (1995-08-01), Naka et al.
patent: 5439906 (1995-08-01), Bock et al.
patent: 5504077 (1996-04-01), Collins et al.
J. Gen. Physiol., vol. 96, pp. 195-215 (Jul. 1990), by M. C. Sanguinetti, et al.
J. Cardiovasc. Pharmacol., vol. 20, (Suppl. 2) pp. S17-S22 (1992), by L. M. Hondeghem.
Claremon David A.
Freidinger Roger M.
Liverton Nigel
Selnick Harold G.
Smith Garry R.
Bigley Frances P.
Bond Robert T.
Daniel Mark R.
Korsen Elliott
Merck & Co. , Inc.
LandOfFree
N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-ami does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-ami, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-ami will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2107309